| UniProt ID | PCNP_HUMAN | |
|---|---|---|
| UniProt AC | Q8WW12 | |
| Protein Name | PEST proteolytic signal-containing nuclear protein | |
| Gene Name | PCNP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 178 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | May be involved in cell cycle regulation.. | |
| Protein Sequence | MADGKAGDEKPEKSQRAGAAGGPEEEAEKPVKTKTVSSSNGGESSSRSAEKRSAEEEAADLPTKPTKISKFGFAIGSQTTKKASAISIKLGSSKPKETVPTLAPKTLSVAAAFNEDEDSEPEEMPPEAKMRMKNIGRDTPTSAGPNSFNKGKHGFSDNQKLWERNIKSHLGNVHDQDN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MADGKAGDE ------CCCCCCCCC | 33.97 | 20154145 | |
| 5 | Acetylation | ---MADGKAGDEKPE ---CCCCCCCCCCCH | 50.14 | 22424773 | |
| 10 | Ubiquitination | DGKAGDEKPEKSQRA CCCCCCCCCHHHHHC | 64.32 | 24816145 | |
| 14 | Phosphorylation | GDEKPEKSQRAGAAG CCCCCHHHHHCCCCC | 24.20 | - | |
| 16 | Methylation | EKPEKSQRAGAAGGP CCCHHHHHCCCCCCC | 41.92 | 115486695 | |
| 29 | Acetylation | GPEEEAEKPVKTKTV CCHHHHCCCCCCCEE | 63.26 | 23954790 | |
| 29 | Ubiquitination | GPEEEAEKPVKTKTV CCHHHHCCCCCCCEE | 63.26 | 33845483 | |
| 32 | Ubiquitination | EEAEKPVKTKTVSSS HHHCCCCCCCEEECC | 53.48 | 24816145 | |
| 32 | Acetylation | EEAEKPVKTKTVSSS HHHCCCCCCCEEECC | 53.48 | 25953088 | |
| 35 | Phosphorylation | EKPVKTKTVSSSNGG CCCCCCCEEECCCCC | 30.74 | 22468782 | |
| 37 | Phosphorylation | PVKTKTVSSSNGGES CCCCCEEECCCCCCC | 33.03 | 26657352 | |
| 38 | Phosphorylation | VKTKTVSSSNGGESS CCCCEEECCCCCCCC | 24.40 | 26657352 | |
| 39 | Phosphorylation | KTKTVSSSNGGESSS CCCEEECCCCCCCCC | 31.80 | 22468782 | |
| 44 | Ubiquitination | SSSNGGESSSRSAEK ECCCCCCCCCCHHHH | 36.57 | 33845483 | |
| 44 | Phosphorylation | SSSNGGESSSRSAEK ECCCCCCCCCCHHHH | 36.57 | 28102081 | |
| 45 | Phosphorylation | SSNGGESSSRSAEKR CCCCCCCCCCHHHHH | 26.01 | 30576142 | |
| 46 | Phosphorylation | SNGGESSSRSAEKRS CCCCCCCCCHHHHHH | 39.26 | 24719451 | |
| 47 | Ubiquitination | NGGESSSRSAEKRSA CCCCCCCCHHHHHHH | 41.66 | 32015554 | |
| 48 | Phosphorylation | GGESSSRSAEKRSAE CCCCCCCHHHHHHHH | 42.60 | 26657352 | |
| 53 | Phosphorylation | SRSAEKRSAEEEAAD CCHHHHHHHHHHHCC | 51.61 | 29255136 | |
| 63 | Phosphorylation | EEAADLPTKPTKISK HHHCCCCCCCCEEHH | 57.88 | 20071362 | |
| 64 | Ubiquitination | EAADLPTKPTKISKF HHCCCCCCCCEEHHC | 49.07 | 33845483 | |
| 64 | Acetylation | EAADLPTKPTKISKF HHCCCCCCCCEEHHC | 49.07 | 19608861 | |
| 64 | Malonylation | EAADLPTKPTKISKF HHCCCCCCCCEEHHC | 49.07 | 26320211 | |
| 66 | Phosphorylation | ADLPTKPTKISKFGF CCCCCCCCEEHHCCE | 42.43 | 25159151 | |
| 66 | O-linked_Glycosylation | ADLPTKPTKISKFGF CCCCCCCCEEHHCCE | 42.43 | OGP | |
| 67 | Ubiquitination | DLPTKPTKISKFGFA CCCCCCCEEHHCCEE | 54.21 | 32015554 | |
| 67 | Acetylation | DLPTKPTKISKFGFA CCCCCCCEEHHCCEE | 54.21 | 21466224 | |
| 69 | Phosphorylation | PTKPTKISKFGFAIG CCCCCEEHHCCEECC | 24.40 | 20068231 | |
| 69 | Ubiquitination | PTKPTKISKFGFAIG CCCCCEEHHCCEECC | 24.40 | 33845483 | |
| 70 | Methylation | TKPTKISKFGFAIGS CCCCEEHHCCEECCC | 53.64 | 90767 | |
| 70 | Acetylation | TKPTKISKFGFAIGS CCCCEEHHCCEECCC | 53.64 | 25953088 | |
| 76 | Ubiquitination | SKFGFAIGSQTTKKA HHCCEECCCCCCCCE | 15.40 | 33845483 | |
| 77 | O-linked_Glycosylation | KFGFAIGSQTTKKAS HCCEECCCCCCCCEE | 20.45 | OGP | |
| 77 | Phosphorylation | KFGFAIGSQTTKKAS HCCEECCCCCCCCEE | 20.45 | 23401153 | |
| 79 | O-linked_Glycosylation | GFAIGSQTTKKASAI CEECCCCCCCCEEEE | 42.13 | OGP | |
| 79 | Phosphorylation | GFAIGSQTTKKASAI CEECCCCCCCCEEEE | 42.13 | 25159151 | |
| 80 | O-linked_Glycosylation | FAIGSQTTKKASAIS EECCCCCCCCEEEEE | 23.94 | OGP | |
| 80 | Phosphorylation | FAIGSQTTKKASAIS EECCCCCCCCEEEEE | 23.94 | 25159151 | |
| 81 | Acetylation | AIGSQTTKKASAISI ECCCCCCCCEEEEEE | 50.13 | 25953088 | |
| 82 | Ubiquitination | IGSQTTKKASAISIK CCCCCCCCEEEEEEE | 45.54 | 29967540 | |
| 84 | O-linked_Glycosylation | SQTTKKASAISIKLG CCCCCCEEEEEEECC | 34.71 | 30059200 | |
| 84 | Phosphorylation | SQTTKKASAISIKLG CCCCCCEEEEEEECC | 34.71 | 30266825 | |
| 86 | Phosphorylation | TTKKASAISIKLGSS CCCCEEEEEEECCCC | 3.97 | 32142685 | |
| 87 | Phosphorylation | TKKASAISIKLGSSK CCCEEEEEEECCCCC | 17.25 | 23401153 | |
| 89 | Ubiquitination | KASAISIKLGSSKPK CEEEEEEECCCCCCC | 39.75 | 33845483 | |
| 89 | Acetylation | KASAISIKLGSSKPK CEEEEEEECCCCCCC | 39.75 | 25953088 | |
| 92 | Phosphorylation | AISIKLGSSKPKETV EEEEECCCCCCCCCC | 45.70 | - | |
| 94 | Acetylation | SIKLGSSKPKETVPT EEECCCCCCCCCCCC | 62.90 | 25953088 | |
| 96 | Ubiquitination | KLGSSKPKETVPTLA ECCCCCCCCCCCCCC | 70.52 | 33845483 | |
| 98 | Phosphorylation | GSSKPKETVPTLAPK CCCCCCCCCCCCCCC | 37.60 | 20068231 | |
| 99 | Phosphorylation | SSKPKETVPTLAPKT CCCCCCCCCCCCCCC | 3.41 | 32142685 | |
| 101 | O-linked_Glycosylation | KPKETVPTLAPKTLS CCCCCCCCCCCCCHH | 31.08 | 30059200 | |
| 101 | Phosphorylation | KPKETVPTLAPKTLS CCCCCCCCCCCCCHH | 31.08 | 20068231 | |
| 106 | Phosphorylation | VPTLAPKTLSVAAAF CCCCCCCCHHHHHHH | 24.17 | 30278072 | |
| 108 | Phosphorylation | TLAPKTLSVAAAFNE CCCCCCHHHHHHHCC | 18.23 | 29255136 | |
| 108 (in isoform 2) | Phosphorylation | - | 18.23 | 19053533 | |
| 114 | Phosphorylation | LSVAAAFNEDEDSEP HHHHHHHCCCCCCCC | 51.59 | 32142685 | |
| 117 | Ubiquitination | AAAFNEDEDSEPEEM HHHHCCCCCCCCCCC | 58.20 | 32015554 | |
| 118 | Phosphorylation | AAFNEDEDSEPEEMP HHHCCCCCCCCCCCC | 71.30 | 32142685 | |
| 119 | Ubiquitination | AFNEDEDSEPEEMPP HHCCCCCCCCCCCCH | 53.67 | 29967540 | |
| 119 | Phosphorylation | AFNEDEDSEPEEMPP HHCCCCCCCCCCCCH | 53.67 | 19664994 | |
| 120 (in isoform 2) | Phosphorylation | - | 69.88 | 19053533 | |
| 121 (in isoform 2) | Phosphorylation | - | 46.96 | 19053533 | |
| 125 | Ubiquitination | DSEPEEMPPEAKMRM CCCCCCCCHHHHHHH | 27.19 | 32015554 | |
| 127 | Ubiquitination | EPEEMPPEAKMRMKN CCCCCCHHHHHHHHH | 55.86 | 32015554 | |
| 130 | Ubiquitination | EMPPEAKMRMKNIGR CCCHHHHHHHHHCCC | 6.97 | 32142685 | |
| 133 | Methylation | PEAKMRMKNIGRDTP HHHHHHHHHCCCCCC | 34.74 | 116253289 | |
| 134 | Ubiquitination | EAKMRMKNIGRDTPT HHHHHHHHCCCCCCC | 32.38 | 29967540 | |
| 135 | Ubiquitination | AKMRMKNIGRDTPTS HHHHHHHCCCCCCCC | 3.90 | 32015554 | |
| 138 | Phosphorylation | RMKNIGRDTPTSAGP HHHHCCCCCCCCCCC | 52.39 | 32142685 | |
| 139 | Phosphorylation | MKNIGRDTPTSAGPN HHHCCCCCCCCCCCC | 27.40 | 29255136 | |
| 140 | Ubiquitination | KNIGRDTPTSAGPNS HHCCCCCCCCCCCCC | 28.75 | 32015554 | |
| 141 | Phosphorylation | NIGRDTPTSAGPNSF HCCCCCCCCCCCCCC | 33.05 | 22167270 | |
| 142 | O-linked_Glycosylation | IGRDTPTSAGPNSFN CCCCCCCCCCCCCCC | 32.22 | 30059200 | |
| 142 | Ubiquitination | IGRDTPTSAGPNSFN CCCCCCCCCCCCCCC | 32.22 | 29967540 | |
| 142 | Phosphorylation | IGRDTPTSAGPNSFN CCCCCCCCCCCCCCC | 32.22 | 30266825 | |
| 147 | Phosphorylation | PTSAGPNSFNKGKHG CCCCCCCCCCCCCCC | 33.07 | 29255136 | |
| 149 | Ubiquitination | SAGPNSFNKGKHGFS CCCCCCCCCCCCCCC | 52.57 | 32015554 | |
| 150 | Ubiquitination | AGPNSFNKGKHGFSD CCCCCCCCCCCCCCC | 68.29 | 32015554 | |
| 150 | Acetylation | AGPNSFNKGKHGFSD CCCCCCCCCCCCCCC | 68.29 | 19608861 | |
| 150 | Methylation | AGPNSFNKGKHGFSD CCCCCCCCCCCCCCC | 68.29 | 19608861 | |
| 151 | Ubiquitination | GPNSFNKGKHGFSDN CCCCCCCCCCCCCCH | 28.44 | 29967540 | |
| 152 | Ubiquitination | PNSFNKGKHGFSDNQ CCCCCCCCCCCCCHH | 42.01 | 19608861 | |
| 152 | Methylation | PNSFNKGKHGFSDNQ CCCCCCCCCCCCCHH | 42.01 | 19608861 | |
| 152 | Acetylation | PNSFNKGKHGFSDNQ CCCCCCCCCCCCCHH | 42.01 | 19608861 | |
| 156 | Phosphorylation | NKGKHGFSDNQKLWE CCCCCCCCCHHHHHH | 40.00 | 30576142 | |
| 159 | Ubiquitination | KHGFSDNQKLWERNI CCCCCCHHHHHHHHH | 47.40 | 32015554 | |
| 160 | Ubiquitination | HGFSDNQKLWERNIK CCCCCHHHHHHHHHH | 62.92 | 32015554 | |
| 160 | Acetylation | HGFSDNQKLWERNIK CCCCCHHHHHHHHHH | 62.92 | 25953088 | |
| 166 | Ubiquitination | QKLWERNIKSHLGNV HHHHHHHHHHHHCCC | 6.40 | 29967540 | |
| 167 | Ubiquitination | KLWERNIKSHLGNVH HHHHHHHHHHHCCCC | 35.06 | 29967540 | |
| 167 | Acetylation | KLWERNIKSHLGNVH HHHHHHHHHHHCCCC | 35.06 | 25953088 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PCNP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PCNP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| UHRF2_HUMAN | UHRF2 | physical | 14741369 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-64; LYS-150 AND LYS-152, ANDMASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119 AND SER-147, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-87; SER-119 AND THR-139,AND MASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-66; SER-69; SER-77;THR-139; SER-142 AND SER-147, AND MASS SPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-139, AND MASSSPECTROMETRY. | |